News Provided By On Demand Pharmaceuticals
Rockville, MD – December 29, 2025 – On Demand Pharmaceuticals (ODP), a leader in advanced, on-demand pharmaceutical manufacturing, applauds the Trump Administration and the Centers for Medicare & Medicaid Services (CMS) for today’s historic announcement of $50 billion in funding awards to all 50 states through the Rural Health Transformation Program.
This unprecedented investment, the largest federal commitment to rural health care in American history, will empower states to expand access to quality care, strengthen the rural health workforce, modernize facilities and technology, and deploy innovative care models that bring dependable, high-quality health services directly to rural communities.
At ODP, we are uniquely positioned to support this transformative initiative. Our proprietary Pharmacy on Demand® technology enables rapid, decentralized production of essential medicines right where they are needed most, helping to mitigate critical drug shortages and bolster resilient, U.S.-based supply chains. By producing medications on-site or near-point-of-care, we can reduce vulnerabilities in traditional manufacturing, ensure timely access to life-saving drugs in remote areas, and align perfectly with the program’s goals of innovation and long-term sustainability in rural health care.
We commend President Trump and Congressional leadership for prioritizing rural America and delivering on the promise that access to health care should never be determined by zip code or be dependent on a foreign nation. On Demand Pharmaceuticals stands ready to partner with states, rural providers, and CMS to leverage this funding for groundbreaking solutions that secure domestic pharmaceutical manufacturing and address ongoing shortages affecting rural hospitals and patients.
We look forward to collaborating across as many states as possible to maximize the impact of these vital resources.
Media Contact:
Jarrod Borkat
Chief Strategic and Commercial Officer
On Demand Pharmaceuticals
[email protected]
website: www.ondemandpharma.com